CIBC Private Wealth Group
SLDB icon

CIBC Private Wealth Group’s Solid Biosciences SLDB Stock Holding History

CIBC Private Wealth Group’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$173K Hold
30,600
– – ﹤0.01% 1259
2025
Q3 		$189K Hold
30,600
– – ﹤0.01% 1211
2025
Q2 		$149K Hold
30,600
– – ﹤0.01% 1238
2025
Q1 		$81.7K Buy
+30,600
New +$131K ﹤0.01% 1429
2018
Q2 		– Sell
-55
Closed -$6K – 2080
2018
Q1 		$6K Buy
+55
New +$18.6K ﹤0.01% 1635

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CIBC Private Wealth Group's SLDB Position: Q4 2025 in Review

CIBC Private Wealth Group held its Solid Biosciences (SLDB) position steady in Q4 2025 at 30,600 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #1259.

CIBC Private Wealth Group first reported a position in SLDB in Q1 2018 and has held it in 5 quarters since. The position peaked at $189K in Q3 2025. 130 funds tracked by Wall St. Rank hold SLDB as of Q4 2025.

  • CIBC Private Wealth Group held 30,600 shares of Solid Biosciences worth $173K as of Q4 2025.
  • CIBC Private Wealth Group left its Solid Biosciences share count unchanged in Q4 2025.
  • Solid Biosciences made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1259 holding.
  • CIBC Private Wealth Group first reported a position in Solid Biosciences in Q1 2018 and has held it in 5 quarters since.
  • CIBC Private Wealth Group's Solid Biosciences position peaked at $189K in Q3 2025.
  • 130 funds tracked by Wall St. Rank held Solid Biosciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.